𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors

✍ Scribed by Luciano Scopece; Enrico Franceschi; Giovanna Cavallo; Anna Paioli; Gabriele Paioli; Rosa Conforti; Emanuela Palmerini; Carlotta Berzioli; Federica Spagnolli; Roberta Degli Esposti; Lucio Crinò


Publisher
Springer US
Year
2006
Tongue
English
Weight
151 KB
Volume
79
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Second-line treatment with carboplatin f
✍ Riccardo Soffietti; Mauro Nobile; Roberta Rudà; Marzia Borgognone; Alessandra Co 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

## Abstract ## BACKGROUND The efficacy of second‐line chemotherapy for patients with recurrent or progressive oligodendroglial tumors is limited. In the current study, the authors investigated the use of carboplatin as a second‐line chemotherapeutic agent against these types of tumors. ## METHODS

Chemotherapy in patients with recurrent
✍ Alba A. Brandes; Pietro Amistà; Marina Gardiman; Lorenzo Volpin; Daniela Danieli 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

## BACKGROUND. Recurrent central neurocytoma is very rare and to the authors' knowledge data regarding its response to chemotherapy currently are not available. ## METHODS. Three patients with progressive neurocytoma received chemotherapy after their informed consent was obtained. Disease recurre

Failure of granulocyte-macrophage colony
✍ Marina, Neyssa M. ;Shema, Sarah J. ;Bowman, Laura C. ;Rodman, John ;Douglass, Ed 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

## Abstract Ifosfamide, carboplatin, and etoposide (ICE) chemotherapy has promising activity against various solid tumors but produces significant myelotoxicity that might be ameliorated by hematopoietic growth factors. Twelve patients with relapsed solid tumors were treated with ICE chemotherapy.